Antleron

Recently we attended the first edition of the Advanced Therapies Summit in Leuven. At @Antleron we are ready to collaborate & enhance our ecosystem’s resilience for the benefit of patients #atmp #advancedtherapies #celltherapies #genetherapies #tissueengineering #bioprocessing

Our #AstroCardia participation was picked up by media & supporting organizations (@VLAIO_be #FlandersSpace @MEDVIA_be). Watch coverages in Dutch bit.ly/45TadUP French bit.ly/3PDP9f7 English bit.ly/3Lq67eJ #space #heart #ageing #organoids #bioprocesses

Seeking GET-IN PhD candidates to advance gene therapies production: 1) Viral vector production: tackle bottlenecks in efficiency & reproducibility 2) Digital twin & multi-parametric optimization of upstream unit operations for rAAV manufacturing 👉 bit.ly/44J2rwa

It was great to exhibit together with #comate at Knowledge for Growth 2023 in Antwerp. We were thrilled to showcase our collaborative Biodevice-CRO offering materialized in a real-life demonstrator (see image) 👉 bit.ly/461FJjX #KFG2023 @flandersbio @ICsenseNV #biotech

Dieter Hauwaerts brings strategic & operational ATMP excellence to the @antleron team. He is co-founder of Antleron and has acquired an impressive track record with leading pharma & biotech companies 👉 Full story bit.ly/43DCIEh #bioprocess #celltherapy #genetherapy

Finally introducing Maarten Sonnaert, @antleron's first employee & currently chief of operations. In this Fellow Friday, Maarten explains how he arrived on his pioneering & entrepreneurial journey 👉 bit.ly/3KgeBDz #bioprocess #sustainable #personalizedmedicine

According to @trends_be magazine, @antleron ranks Nr. 8 among fastest growing small enterprises in Flemish-Brabant! Our nomination signals that our collaborative development model gains traction in #biotech 👉 antleron.com #belgium #entrepreneurship #celltherapy

More happy 2023 news that give us a boost to keep working hard on #healthcare innovations! Proud to share that @antleron is nominated for 2023 Flemish-Brabant Trends Gazellen award. More on Antleron 👉 antleron.com More on Trends Gazellen 👉 trendsgazellen.be

Kick off 2023... 'Life on Chip' will return as 'HealthTech Summit' in Leuven! The 5th edition examines the current state & collaborative innovation, and we co-organize for 5th time! Check cross-over innovations in #medicine & #health 👉 bit.ly/3Q85rvn @MEDVIA_be

Antleron's end of the year newsletter is out! -> bit.ly/3HMgZm0 It talks about new ideas, collaborations & projects, all together bringing more personalized healthcare closer and faster to patients. Stay updated on Antleron? 👉 lnkd.in/dKvTr2Zx

The 3rd edition of the Tissue Engineering Handbook is out! Our colleagues contributed to the chapter Product and process design: scalable and sustainable tissue-engineered product manufacturing. Read now 👉 bit.ly/3L4IULR #tissueengineering #bioprocesses #atmp

Together with our partners at myNEO, VUB, and QbD group, we work on the future of #cancervaccines. Persomed aims to help treat tumors unresponsive to other treatment modalities by offering a novel, personalized cancer vaccine. Read BioVox article bit.ly/3XFNub8

At the Infinite-@ANSYS User Meeting in #Eindhoven on Oct. 14, @Antleron CEO Jan Schrooten will present an inspiring testimonial on the innovative deployment of in-silico tools as part of a digital twin 👉 bit.ly/3RW3cdU #simulation #insilico #digitaltwins #hybridmodels

Meet KU Leuven professor Rik Gijsbers. Rik talks about his motivations to become a scientist. And why he decided to take a step into industry by joining @antleron as consultant, strengthening our @ATMP expertise 👉 bit.ly/3NiereC #viralvecor #genetherapy #celltherapy

.@antleron was invited to join today SME BioForum organized by @EuropaBio. Focus : Advanced Therapy Medicinal Products (ATMP) in Europe & how the #regulatory & market access landscape influences their availability to the patients 👉 bit.ly/3a9brTG #cellandgenetherapy

Happy to announce that Jan Schrooten, CEO Antleron, joins MEDVIA as member of the Board of Directors. MEDVIA is newly established #FlandersHealthTech innovation cluster 👉 lnkd.in/eWT5YPG9 #biotechnology #grants #cluster #ecosystem #digitalhealth #medicaltechnology

Our @antleron Fellows contributed to the 3rd edition of 'Tissue Engineering', a well-received handbook originally published in 2014 (@ElsevierConnect). They explain how #tissueengineering manufacturing becomes sustainable & scalable 👉 bit.ly/3L4IULR #bioprocess @uqui_5

Customized 3D bioreactors are essential in helping produce huge numbers of cells. Using 3D printing as part of @antleron toolbox, we enable bioprocess solutions by developing customized fixed beds that result in scalable & sustainable cell processing 👉 bit.ly/3uJUkQs

Blogpost on how we apply 3D printing in R&D projects. Additive Manufacturing offers flexibility to fast-track & scale design & dev. of custom solutions for cell & gene therapy & diagnostics markets 👉 lnkd.in/datfN4NQ #3dprinting #additivemanufacturing #bioprocess

On March 30, during virtual @ANSYS SimCare Conf, @antleron CEO Jan Schrooten will join @prithbanarjee (CTO, Ansys) for 11 AM 'The process to Adopt & Deploy' Session. More info & register now 👉 bit.ly/3tABf2n #computationalmodeling #flowsimulation #pharma #bioprocess